CHI3L1 and systemic sclerosis: YKL-40 has also been implicated in a variety of non-pulmonary inflammatory diseases, such as rheumatoid arthritis [12], systemic sclerosis [13], myocardial infarction [14], meningitis[15], diabetes [16] and cancer[17].